Current Report Filing (8-k)
February 23 2022 - 4:50PM
Edgar (US Regulatory)
0001491487
false
999077
0001491487
2022-02-16
2022-02-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 16, 2022
TAKUNG ART CO., LTD
(Exact name of Registrant as specified in its
charter)
Delaware |
|
001-38036 |
|
26-4731758 |
(State or other jurisdiction
of Incorporation) |
|
(Commission
File No.) |
|
(IRS Employer
Identification No.) |
Room
709 Tower 2, Admiralty Centre, 18 Harcourt Road, Admiralty, Hong Kong
(Address of Principal Executive Offices)
Registrant’s telephone number:
+852 3158
0977
________________________________________________
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading
Symbol(s) |
Name of each exchange on which
registered |
Common Stock, par value $0.001 per share |
TKAT |
NYSE American |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
Item 1.01 |
Entry into a Material Definitive Agreement. |
On February 16,
2022, Takung Art Co., Ltd., a Delaware corporation (the “Company”) entered into certain securities purchase
agreement (the “Feb 16 SPA”) with certain “non-U.S. Persons” (the “Purchasers”) as
defined in Regulation S of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to which the
Company agreed to sell 11,770,240 units, each consisting of one share of the common stock of the Company, par value $0.001 per share
(the “Common Stock”) and a warrant to purchase three shares of Common Stock. The purchase price of each Unit is
$2.5488. The gross proceeds to the Company from this offering will be approximately $30 million.
Upon further discussion among
the parties, on February 23, 2022, the Company and the Purchasers agreed to terminate the Feb 16 SPA pursuant to certain Termination Agreement
and entered into a new securities purchase agreement (the “Feb 23 SPA”). The Feb 16 SPA and the Feb 23 SPA are substantially
on the same terms except the per Unit purchase price. Pursuant to the Feb 23 SPA, the Company agreed to sell 11,952,190 units (the “Units”),
each consisting of one share of Common Stock (the “Shares”) and a warrant (the “Warrant”) to purchase
three shares of Common Stock. The purchase price of each Unit is $2.51. The gross proceeds to the Company from this offering will be approximately
$30 million.
The issuance and sale of the
Units is exempted from the registration requirement of the Securities Act pursuant to Regulation S promulgated thereunder.
The Warrants are exercisable
at any time after the six-month anniversary of the issuance date at an initial exercise price of $3.1375 for cash (the “Warrant
Shares”). The Warrants may also be exercised cashlessly if at any time after the nine-month anniversary of the issuance date,
there is no effective registration statement registering, or no current prospectus available for, the resale of the Warrant Shares. The
Warrants shall expire five and a half years from its date of issuance. The Warrants are subject to customary anti-dilution provisions
reflecting stock dividends and splits or other similar transactions.
The parties to the Feb
23 SPA have each made customary representations, warranties and covenants, including, among other things, (a) the Investors are
“non-U.S. Persons” as defined in Regulation S and are acquiring the Units for the purpose of investment, (b) the
absence of any undisclosed material adverse effects, and (c) the absence of legal proceedings that affect the completion of the
transaction contemplated by the Feb 23 SPA.
The Feb 23 SPA is
subject to various conditions to closing including NYSE American’s completion of its review of the notification to NYSE American
regarding the listing of the Units. The Units to be issued in the Offering are exempt from the registration requirements of the
Securities Act of 1933, as amended, pursuant to Regulation S promulgated thereunder.
The net proceeds of this offering
shall be used by the Company in connection with the Company’s general corporate purposes, working capital, or other related business
as approved by the board of directors of the Company.
The forms of the Feb 23
SPA and Warrant and the Termination Agreement dated February 23, 2022 are filed as Exhibits 10.1, 10.2 and 10.3 to this Current
Report on Form 8-K, respectively, and such documents are incorporated herein by reference. The foregoing is only a brief
description of the material terms of the Feb 23 SPA the Warrant, and the Termination Agreement does not purport to be a complete
description of the rights and obligations of the parties thereunder and are qualified in their entirety by reference to such
exhibits.
Item 9.01. |
Financial Statements and Exhibits. |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: February 23, 2022
|
Takung Art Co., Ltd |
|
|
|
/s/ Kuangtao Wang |
|
Name: Kuangtao Wang |
|
Title: Co-Chief Executive Officer |
Takung Art (AMEX:TKAT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Takung Art (AMEX:TKAT)
Historical Stock Chart
From Apr 2023 to Apr 2024